Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

Contemporary Patterns of High-Efficacy Disease Modifying Therapy Use in Korean Patients with Relapsing-Remitting Multiple Sclerosis: Su-Hyun Kim, Na Young Park, Min Jeong Kim, Ki Hoon Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2023;14(2):99-105. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.99; Full text PubReader ePub PDF

National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Young Nam Kwon, Ki Hoon Kim, Seung Woo Kim, Sa-Yoon Kang, Sung-Min Kim, Woojun Kim, Jun-Soon Kim, Ho Jin Kim, Tai-Seung Nam, Ju-Hong Min, Min Su Park, Jin Myoung Seok, Eunhee Sohn, Kyong Jin Shin, Hyun-June Shin, Eun-Jae Lee, Ha Young Shin; J Mult Scler Neuroimmunol. 2023;14(2):87-98. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.87; Full text PubReader ePub PDF

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

4,835	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
1,440	Rituximab Treatment for Neuroimmunologic Disorders
1,321	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
1,129	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
1,021	New Therapeutic Agents in Myasthenia Gravis

Cited By
1

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: icandr@cau.ac.kr